-
EP2542233
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2542233
| EP2542233 - Composition comprising as active ingredient L-carnitine in combination with hydroxykynurenine-O-beta-DL-glucoside, for the prevention and/or treatment of pathologies of the eye due to ultraviolet radiation [Right-click to bookmark this link] | |||
| Former [2013/02] | COMPOSITION COMPRISING AS ACTIVE INGREDIENT L-CARNITINE IN COMBINATION WITH HYDROXYKYNURENNINE-0-BETA-DL-GLUCOSIDE, FOR THE PREVENTION AND/OR TREATMENT OF PATHOLOGIES OF THE EYE DUE TO ULTRAVIOLET RADIATION | ||
| [2013/39] | Status | The application is deemed to be withdrawn Status updated on 08.01.2016 Database last updated on 18.11.2024 | Most recent event Tooltip | 08.01.2016 | Application deemed to be withdrawn | published on 10.02.2016 [2016/06] | Applicant(s) | For all designated states SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Viale Shakespeare 47 00147 Roma / IT | [2013/02] | Inventor(s) | 01 /
PESCOSOLIDO, Nicola Via Paolo Albera 33 I-00181 Rome / IT | 02 /
KOVERECH, Aleardo Via Aurelia Antica 200 I-00165 Rome / IT | [2013/02] | Representative(s) | Tagliafico, Giulia Sigma-Tau Industrie Farmaceutiche Riunite SpA Via Pontina Km. 30.400 00040 Pomezia RM / IT | [N/P] |
| Former [2013/02] | Tagliafico, Giulia Sigma-Tau Industrie Farmaceutiche Riunite SpA Via Pontina Km. 30.400 00040 Pomezia RM / IT | Application number, filing date | 11702470.3 | 10.02.2011 | WO2011EP51941 | Priority number, date | EP20100155501 | 04.03.2010 Original published format: EP 10155501 | [2013/02] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2011107334 | Date: | 09.09.2011 | Language: | EN | [2011/36] | Type: | A1 Application with search report | No.: | EP2542233 | Date: | 09.01.2013 | Language: | EN | The application published by WIPO in one of the EPO official languages on 09.09.2011 takes the place of the publication of the European patent application. | [2013/02] | Search report(s) | International search report - published on: | EP | 09.09.2011 | Classification | IPC: | A61K31/205, A61K31/7036, A61P27/02 | [2013/02] | CPC: |
A61K31/205 (EP,KR,US);
A61K31/7036 (EP,KR,US);
A61P27/02 (EP);
A61P27/12 (EP);
A61P43/00 (EP)
| C-Set: |
A61K31/205, A61K2300/00 (EP,US);
A61K31/7036, A61K2300/00 (US,EP) | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2013/02] | Extension states | BA | 23.08.2012 | ME | 23.08.2012 | Title | German: | Zusammensetzung mit L-Carnitin als aktivem Bestandteil in Kombination mit hydroxykynurenine-O-beta-DL-glucoside,zur Verhinderung und/oder Behandlung von Augenkrankheiten, die aufgrund der ultravioletten Strahlung entstanden sind | [2013/39] | English: | Composition comprising as active ingredient L-carnitine in combination with hydroxykynurenine-O-beta-DL-glucoside, for the prevention and/or treatment of pathologies of the eye due to ultraviolet radiation | [2013/39] | French: | Composition comprenant une L-carnitine en tant que principe actif en combinaison avec le glucoside de l'hydroxykynurénine, pour la prévention et/ou le traitement de pathologies de l'oeil dues au rayonnement ultraviolet | [2013/39] |
| Former [2013/02] | ZUSAMMENSETZUNGEN MIT L-CARNITIN ALS WIRKSTOFF IN KOMBINATION MIT HYDROXYKYNURENNIN-0-BETA-DL-GLUCOSID ZUR PRÄVENTION UND/ODER BEHANDLUNG VON AUGENLEIDEN INFOLGE VON UV-STRAHLUNG | ||
| Former [2013/02] | COMPOSITION COMPRISING AS ACTIVE INGREDIENT L-CARNITINE IN COMBINATION WITH HYDROXYKYNURENNINE-0-BETA-DL-GLUCOSIDE, FOR THE PREVENTION AND/OR TREATMENT OF PATHOLOGIES OF THE EYE DUE TO ULTRAVIOLET RADIATION | ||
| Former [2013/02] | COMPOSITION COMPRENANT AU TITRE DE PRINCIPE ACTIF DE LA L-CARNITINE EN COMBINAISON AVEC L'HYDROXYKYNURÉNINE-O-BÊTA-DL-GLUCOSIDE, DANS LE TRAITEMENT PROPHYLACTIQUE ET/OU THÉRAPEUTIQUE DE PATHOLOGIES OCULAIRES DUES AUX RAYONNEMENTS ULTRAVIOLETS | Entry into regional phase | 23.08.2012 | National basic fee paid | 23.08.2012 | Designation fee(s) paid | 23.08.2012 | Examination fee paid | Examination procedure | 23.08.2012 | Examination requested [2013/02] | 18.03.2013 | Amendment by applicant (claims and/or description) | 26.08.2013 | Despatch of a communication from the examining division (Time limit: M04) | 06.12.2013 | Reply to a communication from the examining division | 17.06.2015 | Despatch of a communication from the examining division (Time limit: M02) | 28.08.2015 | Application deemed to be withdrawn, date of legal effect [2016/06] | 25.09.2015 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2016/06] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 26.08.2013 | Fees paid | Renewal fee | 27.02.2013 | Renewal fee patent year 03 | 27.02.2014 | Renewal fee patent year 04 | 26.02.2015 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [ID]WO2008077712 (SIGMA TAU IND FARMACEUTI [IT], et al) [ID] 1-14 * page 11, line 23 - page 13, line 7 * * page 22, line 19 - page 23; claims 13, 14 * | Examination | WO2008077712 | by applicant | US5883127 | US5037851 | US5145871 | US5432199 | US5876709 | US2004042072 | WO2008077712 | US4254053 | - DOC OPHTHALMOL., (1994), vol. 88, no. 3-4, page 339 | - J. PHYSIOL., (1969), vol. 203, pages 411 - 417 | - EXP. EYE RES., (1988), vol. 47, pages 819 - 824 | - EXP. EYE RES., (1991), vol. 53, pages 753 - 758 | - CONTACTOLOGIA, (1982), vol. 4F, pages 101 - 103 | - INT. J. OF PHARM., (1986), vol. 33, pages 201 - 217 | - PHOTOCHEM. PHOTOBIOL., (1989), vol. 49, pages 175 - 180 | - ARCH. OPHTHALMOL., (1987), vol. 115, pages 1031 - 1035 | - INVEST. OPHTHALMOL. VIS. SCI., (1986), vol. 27, pages 1123 - 1130 | - EYE, (2005), vol. 19, pages 431 - 441 | - BIOCHEM., (20011201), vol. 299, no. 1, pages 78 - 83 |